Tensha Therapeutics VP of Business Development Salary | Comparably
Tensha Therapeutics develops small molecule bromodomain inhibitors to treat cancer and other serious disorders. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
102

Tensha Therapeutics VP of Business Development Salary

The average Tensha Therapeutics VP of Business Development earns an estimated $205,040 annually. Tensha Therapeutics' VP of Business Development compensation is $6,061 less than the US average for a VP of Business Development.

The Business Development Department at Tensha Therapeutics earns $2,298 more on average than the Legal Department.

Last updated 5 years ago.

$37k
$90k
$145k
$200k
$410k
$824k
$205,040
Average Compensation
$205,040
avg. base

VP of Business Development Salaries at Tensha Therapeutics

VPs of Business Development earn $11,703 more than Directors of Business Development.

Director of Business Development
$193k*
Business Development Manager
$140k*
Account Executive
$132k*
Account Manager
$89k*
* estimated salary

Compensation at Tensha Therapeutics by Department

The Business Development Department averages $2,298 more than the Legal Department, and $3,494 less than the HR Department

HR
$117,493 Avg. total comp.
+$3k
Business Development
$113,999 Avg. total comp.
Legal
$111,701 Avg. total comp.
-$2k

VP of Business Development Compensation by Gender (All Companies)

The average female VP of Business Development at companies similar size to Tensha Therapeutics reported making $315,250, while the average male VP of Business Development at similar sized companies reported making $283,234.

VP of Business Development Compensation by Ethnicity (All Companies)

The average Caucasian VP of Business Development at companies similar size to Tensha Therapeutics reported making $304,764, while the average African American/Black VP of Business Development at similar sized companies reported making $140,000.

How VPs of Business Development at Tensha Therapeutics Rate Their Compensation

100% say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Tensha Therapeutics

×
Rate your company